A Randomized Comparison of 5-FU Infusion and Bolus Cisplatin as an Adjunct to Radiation Therapy, Versus Radiation Therapy Alone in Selected Patients with Stages I-A2, I-B and II-A Carcinoma of the Cervix Following Radical Hysterectomy and Node Dissection

Economic evaluations in NCI-sponsored network cancer clinical trials

VT Nghiem;R Vaidya;GH Lyman;DL Hershman;SD Ramsey;JM Unger Value in Health Dec;23(12):1653-1661. doi: 10.1016/j.jval.2020.08.2095. Epub 2020 Oct 9

PMid: PMID33248521 | PMC number: PMC8262264

Association of Patient Demographic Characteristics and Insurance Status with Survival in Cancer Randomized Clinical Trials with Positive Findings

JM Unger;CD Blanke;M Leblanc;W Barlow;R Vaidya;M Fleury;SD Ramsey;DL Hershman JAMA Network Open Apr 1;3(4):e203842

PMid: PMID32352530 | PMC number: PMC7193331

The effect of positive SWOG treatment trials on survival of patients with cancer in the US population

JM Unger;M Leblanc;CD Blanke JAMA Oncology Oct 1;3(10):1345-1351

PMid: PMID28586789; PMC5710507

The impact of positive SWOG treatment trials on population survival

J Unger;M LeBlanc;C Blanke J Clin Oncol 35, 2017 (suppl; abstr 6513); American Society of Clinical Oncology Annual Meeting (June 2-6, 2017, Chicago, IL), poster discussion

Comparison of survival outcomes among cancer patients treated in and out of clinical trials

J Unger;W Barlow;DP Martin;S Ramsey;M Leblanc;R Etzioni;D Hershman Journal of the National Cancer Institute 106(3):dju002; 2014 Mar 13 [Epub ahead of print];

PMid: PMID24627276 | PMC number: PMC3982777

Modeling the relationship between progression-free survival and overall survival: the phase 2/3 trial

M Redman;B Goldman;M LeBlanc;A Schott;LH Baker Clinical Cancer Research, 19(10):2646-2656;

PMid: PMID23669424 | PMC number: PMC4131693

Reducing uncertainties about the effects of chemoradiotherapy for cervical cancer: a systematic review and meta-analysis of individual patient data from 18 randomized trials [PMC2645100; PMID19001332]

C Vale;JF Tierney;LA Stewart;M Brady;K Dinshaw;A Jakobsen;MK Parmar;G Thomas;T Trimble;DS Alberts;H Chen;S Cikaric;PJ Eifel;M Garipagoaglu;H Keys;N Kantardzic;P Lal;R Lanciano;F Leborgne;V Lorvidhaya;H Onishi;RG Pearcey;E Pras;K Roberts;PG Rose;CW Whitney Journal of Clinical Oncology 26(25):5802-5812

The Southwest Oncology Group: progress in cancer research [PMID18929152]

CA Coltman Seminars in Oncology 35(5):545-552

Rethinking the use of chemotherapy and radiation after radical hysterectomy: a clinical-pathologic analysis of SWOG 8797/GOG 109

SS Im;BJ Monk;J Wang;RJ Stock;WA Peters III;PY Liu;RJ Barrett;JS Berek;L Souhami;P Grisby;W Gordon;DS Alberts Gynecologic Oncology 92:396 (#8)

Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix

WA Peters III;PY Liu;R Barrett II;RJ Stock;BJ Monk;JS Berek;L Souhami;P Grigsby;W Gordon Jr;DS Alberts Classic Papers and Current Comments 7(1):174-181

Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation thereapy alone as adjuvant therapy after radical surgery in high-risk early stage cancer of the cervix

WA Peters III;PY Liu;RJ Barrett;RJ Stock;BJ Monk;JS Berek;L Souhami;P Grigsby;W Gordon Jr;DS Alberts Journal of Clinical Oncology 18(8):1606-1613

Cisplatin, 5-fluorouracil plus radiation therapy are superior to radiation therapy as adjunctive therapy in high-risk, early-stage carcinoma of the cervix after radical hysterectomy and pelvic lymphadenectomy: Report of a phase III intergroup study.

WA Peters, III;PH Liu;R Barrett;W Gordon, Jr.;R Stock;JF Berek;PJ Disaia;L Souhami;PW Grigsby;DS Alberts Proc of the Society of Gynecologic Oncologists :#1